2,6-Dichloroquinoxaline

We are 2,6-Dichloroquinoxaline CAS:18671-97-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 18671-97-1
Product Name: 2,6-Dichloroquinoxaline
Other Name:
2,6-Dichloroquinoxaline
 
Density: 1.5±0.1 g/cm3
Boiling Point: 278.7±35.0 °C at 760 mmHg
Melting Point: 153-157 °C(lit.)
Molecular Formula: C8H4Cl2N2
Molecular Weight: 199.037
Flash Point: 149.1±11.5 °C
Exact Mass: 197.975159
PSA: 25.78000
LogP: 2.95
Vapour Pressure: 0.0±0.6 mmHg at 25°C
Index of Refraction: 1.671
 
Specification
Appearance: White solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Quizalofop-Ethyl CAS: 76578-14-8.
Be used as pesticide intermediate, mainly used to synthesize herbicide Quizalofop-Ethyl.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2,6-Dichloroquinoxaline


Related News: In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.3-trietoxisilil-N- (3-trietoxisililpropil) propan-1-amina CAS:13497-18-2 Any drug or medication is composed of two components.Phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.4-Phenylpiperidine Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
5-methyl-3H-1,3,4-oxadiazol-2-one View Details
N-(5H-Purin-6-yl)benzamide View Details
Hydroxy Tyrosol α-Acetate View Details
2,4-Difluorobenzyl Chloride manufacturer Eledoisin manufacturer 1-amino-2,2-dimethoxypropane manufacturer Boc-D-Homophe-OH manufacturer Dodecyl 2-methylacrylate manufacturer